Clinical trials: Simple Steatosis (SS)
Simple Steatosis (SS), Non-alcoholic Steatohepatitis (NASH)
Gut Microbiota and Modulation of Liver Damage in NAFLD
Several experimental data suggest that gut-derived endotoxin and GM composition can act as a "second hit" or insult to convert hepatic SS to NASH and cause both local hepatic and systemic inflammation.This study's aim is to…
- Conditions
- Simple Steatosis (SS), Non-alcoholic Steatohepatitis (NASH), Obesity
- Trial name
- NCT02158351
- Testing
- liver and white adipose tissue biopsies
- Where
- Italy
- Volunteers
- 44 people
- Sponsor
- University of Roma La Sapienza
Healthy, Simple Steatosis (SS)
New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
The goal of this observational study is to learn if some components of blood or exhaled breath can diagnose people having more fat in their livers than is normal, because of their poorer metabolic health (for example, because of…
- Conditions
- Healthy, Simple Steatosis (SS), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Trial name
- NCT06647095
- Testing
- D-Limonene Gelcaps, Fish Oil Concentrate, 1000 Mg Oral Capsule
- Where
- 2 sites in Czechia
- Volunteers
- 172 people, healthy volunteers welcome
- Sponsor
- General University Hospital, Prague